相关实验视频
Updated: May 6, 2026

09:21
Serum and Plasma Copy Number Detection Using Real-time PCR
Published on: December 15, 2017
11.4K
奥拉巴里布诱导的无形性贫血在一个患有割抗性前列腺癌的患者:一个病例报告
Elrazi A Ali1, Monika Jain1, Akriti Pokhrel2
1Internal Medicine Department, Interfaith Medical Center, One Brooklyn Health, Brooklyn, NY, USA.
Leukemia research reports
|August 23, 2024
概括
一种PARP抑制剂Olaparib治疗前列腺癌,但可能导致罕见的副作用. 这份病例报告详细介绍了一名患者,他在BRCA2阳性癌症的Olaparib治疗后出现了无塑性贫血.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 奥拉巴里布是一种经批准用于转移性割抵抗性前列腺癌 (CRPC) 的多 (ADP-ribose) 聚合酶抑制剂 (PARPi).
- PARPi疗法通过抑制DNA修复来向具有BRCA1/BRCA2突变或同源重组缺陷的癌细胞.
- 虽然在PARPi使用时报告了肌肉发育综合征和急性白血病,但无形性贫血并不是通常相关的不良事件.
关键词:
无形成性贫血是什么?这就是Olaparib.泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia 泛cytopenia前列腺癌是什么意思 前列腺癌是什么意思更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.0K
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
相关概念视频
Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K